Evidence map›Paper›PMID 28266533›Full record

ArticleScientific reports2017

Catch-and-Release of Target Cells Using Aptamer-Conjugated Electroactive Zwitterionic Oligopeptide SAM.

Junko Enomoto, Tatsuto Kageyama, Tatsuya Osaki, Flavia Bonalumi, Francesca Marchese, Alfonso Gautieri, Elena Bianchi, Gabriele Dubini, Chiara Arrigoni, Matteo Moretti and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Junko EnomotoGraduate School of Engineering, Yokohama National University, Japan.
Tatsuto KageyamaGraduate School of Engineering, Yokohama National University, Japan.
Tatsuya OsakiGraduate School of Engineering, Yokohama National University, Japan.
Flavia BonalumiDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Italy.
Francesca MarcheseDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Italy.
Alfonso GautieriDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Italy.
Elena BianchiDepartment of Chemistry, Politecnico di Milan, Italy.
Gabriele DubiniDepartment of Chemistry, Politecnico di Milan, Italy.
Chiara ArrigoniCell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, Italy.
Matteo MorettiCell and Tissue Engineering Laboratory, IRCCS Galeazzi Orthopaedic Institute, Italy.
Junji FukudaGraduate School of Engineering, Yokohama National University, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleic acid aptamers possess attractive features such as specific molecular recognition, high-affinity binding, and rapid acquisition and replication, which could be feasible components for separating specific cells from other cell types. This study demonstrates that aptamers conjugated to an oligopeptide self-assembled monolayer (SAM) can be used to selectively trap human hepatic cancer cells from cell mixtures containing normal human hepatocytes or human fibroblasts. Molecular dynamics calculations have been performed to understand how the configurations of the aptamers are related to the experimental results of selective cell capture. We further demonstrate that the captured hepatic cancer cells can be detached and collected along with electrochemical desorption of the oligopeptide SAM, and by repeating these catch-and-release processes, target cells can be enriched. This combination of capture with aptamers and detachment with electrochemical reactions is a promising tool in various research fields ranging from basic cancer research to tissue engineering applications.

Indexed as

Electrochemical TechniquesAptamers, NucleotideCell Line, TumorCell SeparationHumansOligopeptidesAptamers, NucleotideOligopeptides

Identifiers

PMID28266533
PMCPMC5339905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.